Modalis Therapeutics Corporation Stock: price and insider trades · Japan
株式会社 モダリス
Modalis Therapeutics Corporation: what insiders have been doing
We have very little insider data for Modalis Therapeutics Corporation so far: the most recent filing dates from 4 October 2023. With so few records, no pattern can be drawn yet. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
JP¥30
Analyst consensus
Income statement
EBITDA-JP¥2.1B
Net income-JP¥2.2B0.0% margin
Valuation
P/Book1.0x
Beta0.40
Balance sheet & cash
Market capJP¥2.9B
Free Cash Flow-JP¥2.1B
Profitability & ownership
ROE-59.7%
ROA-36.3%
% insiders8.9%
% institutions3.9%
Last declaration on 4 October 2023
Declarations11 total
- 2.9% of flowShareXTKSEDINET:S100RYZ7
- 15.9% of flowShareXTKSEDINET:S100RD08
- 12.5% of flowShareXTKSEDINET:S100RCBE
- 15.9% of flowShareXTKSEDINET:S100RAO7
- 6.3% of flowShareXTKSEDINET:S100R1YR
- 4.1% of flowShareXTKSEDINET:S100QUUO
- 7.1% of flowShareXTKSEDINET:S100QB1W
- 5.3% of flowShareXTKSEDINET:S100Q3QF
- 8.2% of flowShareXTKSEDINET:S100PXT7
- 11.3% of flowShareXTKSEDINET:S100PX2D
- 10.5% of flowShareXTKSEDINET:S100PSHV
11 of 11 declarations
About Modalis Therapeutics Corporation
株式会社 モダリス is a Japanese company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.
